Purpose: To present a postprocessing approach in optical coherence tomography angiography (OCTA) to facilitate the visualization and interpretation of lesions in age-related macular degeneration with coexisting atrophy and choroidal neovascularization (CNV).
A ge-related macular degeneration (AMD) is the leading cause of severe vision loss in people older than 65 years in the United States. Although early AMD has little impact on visual function, late AMD, defined as the development of neovascular AMD or geographic atrophy (GA), is associated with significant visual impairment. 1 Neovascular AMD is currently treated with intravitreal anti-vascular endothelial growth factor (VEGF) agents with excellent visual outcome. [2] [3] [4] However, eyes undergoing anti-VEGF therapy develop retinal pigment epithelium (RPE) and choriocapillaris atrophy, clinically similar to de novo GA, with slowly progressive decay of visual acuity. [5] [6] [7] Specifically, of patients with choroidal neovascularization (CNV) but no GA at baseline, 38% developed RPE atrophy within a 5-year follow-up period in Comparison to Age-Related Macular Degeneration Treatments Trials. 8 Furthermore, a number of studies have reported the development of new onset CNV in eyes with a baseline diagnosis of GA. [9] [10] [11] [12] Therefore, overlap between atrophy and CNV in late AMD presents a complex scenario for retinal specialists and poses important diagnostic and therapeutic challenges.
Optical coherence tomography angiography (OCTA) provides a noninvasive way to visualize the retinal and choroidal vasculature and is increasingly used by clinicians to supplement conventional diagnostic imaging modalities. Previous studies have demonstrated the ability of OCTA to detect CNV lesions in a range of ocular diseases, including AMD. 13, 14 Recent OCTA studies have demonstrated the technique's utility for detecting preclinical, nonexudative CNV in AMD, 15, 16 automated quantification of CNV lesions, 17 and the development of OCTA parameters for clinical trial end points in eyes with CNV. 18 In this study, we discuss the approach to lesions where OCTA interpretation can be particularly challenging in eyes suspected to have CNV, especially in the presence of concomitant GA, atrophy, and/or subretinal hyperreflective material.
Histologic studies have shown a loss of photoreceptors, RPE, and choriocapillaris in the areas of GA, but have not explored the choroidal vascular remodeling beyond the choriocapillaris. 19, 20 Therefore, details of choroidal remodeling during GA and the fate of the other vascular and stromal layers of the choroid are not well documented. In GA, we have found that distinguishing between normal (residual) choroidal vessels and pathological CNV on en face OCTA can be challenging because they can appear strikingly similar. In fact, CNV formations that have not yet infiltrated through the Bruch membrane have recently been documented on histopathology in eyes with AMD 21 and could potentially be visualized in OCTA.
To address these issues, we propose a novel postprocessing approach that highlights GA and facilitates en face OCTA image interpretation by incorporating structural and flow information within a single image. In addition, we propose a pseudocolor scheme to enhance the visualization of CNV in the outer retinal slab. In a series of eyes with various stages of GA, atrophy, and CNV, we examine the utility of this approach and highlight the importance of using crosssectional OCTA flow images when interpreting en face OCTA in advanced AMD.
Methods
This was a retrospective analysis of patients with AMD recruited by the Department of Ophthalmology at Northwestern University in Chicago, Illinois, between May 2015 and April 2016. This study was approved by the Institutional Review Board of Northwestern University, followed the tenets of the Declaration of Helsinki, and was performed in accordance with the Health Insurance Portability and Accountability Act regulations. Written informed consent was obtained from all participants.
Study Sample
Inclusion criteria included a diagnosis of GA secondary to AMD, equivalent to grade four on the Age-Related Eye Disease Study (AREDS) scale, 22 based on the grading of color fundus photographs, spectral domain OCT (SD-OCT), and fundus autofluorescence analyzed by an experienced retina specialist (A.A.F.). We included both treatment-naive eyes with GA and eyes with atrophy in the setting of anti-VEGF treatment for CNV. Only eyes that had OCTA images without movement or shadow artifacts in the area of interest were considered eligible.
Exclusion criteria included eyes that have undergone surgical retinal repair or those with other retinal diseases that may confound our results such as high myopia (over 7 D). To avoid optical artifacts that may potentially compromise OCTA image quality, we also excluded patients with evidence of significant cataracts, graded above nuclear opalescence Grade 3 or nuclear color Grade 3. Electronic medical records were reviewed to extract demographic and clinical information. Monocular visual acuity was determined for all subjects using Snellen eye charts and converted to the logarithm of the minimum angle of resolution as previously described. 23 
Angiographic Imaging and Image Processing
Optical coherence tomography angiography images were obtained using the RTVue-XR Avanti system (Optovue Inc, Fremont, CA), with split-spectrum amplitude-decorrelation angiography (SSADA) software. 24 This instrument has an A-scan rate of 70,000 scans per second and uses a light source centered on 840 nm with a full-width at half-maximum bandwidth of 45 nm. Each OCTA volume contained 304 · 304 A-scans, with 2 consecutive B-scans (M-B frames) captured at each sampling location. Split-spectrum amplitude-decorrelation angiography was then used to extract OCTA information, resulting in an OCTA volume containing 304 B-scans. We obtained 3 mm 2 · 3 mm 2 scans centered on the fovea or the area of the posterior pole containing GA. Optical coherence tomography angiography scans with a signal strength index score below 50 were not included for further analysis.
En face OCT angiograms were automatically segmented using the built-in software to define the outer retina and choriocapillaris. The outer retinal slab was 40 mm thick, from 71 mm below the inner plexiform layer to 31 mm below the RPE reference line. The choriocapillaris slab was 28 mm thick, from 31 mm to 59 mm below the RPE reference line. The RPE reference line, when the RPE is present, is located at the middle of the hyperreflective RPE band on OCT.
Optovue software includes an algorithm for the outer retinal slab, which automatically removes projection artifacts related to overlying retinal vessels. This algorithm can fail when the anatomy of the retina is pathologically distorted, leading to segmentation errors and failure to remove projection artifacts of retinal vessels on the outer retinal slab. For each OCTA volume, we assessed cross-sectional OCT to identify errors in the segmentation, defined as areas where the segmentation did not follow the preset anatomical location. We then used cross-sectional OCT to determine the location of blood vessels in the outer retinal slab, to appreciate retinal projection artifacts. Another error in this slab occurs with the loss of the RPE, where the outer boundary becomes noticeably displaced into the anterior choroid. When there were failures of the algorithm, we examined the OCT B-scan to confirm the location of the vessels shown in that slab. We took the most superficial layer in which we could appreciate the red flow signal on the OCTA B-scan as the anatomical location of that vessel. We made no attempts to rectify these segmentation artifacts but noted them in our figures.
To identify the zone of GA, we used an OCT sub-RPE slab from the upper border of the choriocapillaris (31 mm below RPE reference) extending down 300 mm into the choroid, the approach developed by Lujan et al. 25 The choroidal slab was exported into ImageJ (developed by Wayne Rasband, National Institutes of Health, Bethesda, MD; available at http://rsb.info.nih. gov/ij/index.html) and converted to a binary GA mask that outlined the GA area. From this image, the borders of the GA were copied onto an en face OCTA of the choriocapillaris, and any blood vessel within the area of GA were pseudocolored on a spectrum from blue to yellow, whereas those outside of the GA were pseudocolored magenta (Figure 1) . If the outer retinal OCTA slab showed blood vessels, these vessels were pseudocolored green and overlaid onto the composite OCTA en face image. Normal choroidal vessels are displaced anteriorly in the area of GA and seen in the choriocapillaris slab. B. En face structural OCT slab of the choroid with cross-section below. Extra signal penetrating the choroid in GA appears bright on the en face image. C. Binary rendition of the OCT slab of the choroid used to select the area of GA (white). Choroidal illumination is seen in the area of GA on the cross-section. D. Pseudocolored OCTA of the choriocapillaris highlights GA boundaries. Blood vessels in GA are pseudocolored on a spectrum from blue to yellow and vessels in areas with relatively intact retinal pigment epithelial vessels are pseudocolored magenta. Red flow overlay on cross-sectional OCTA demonstrates a choroidal vessel abutting the Bruch membrane in GA (blue arrow). White arrow points to a choroidal vessel located more posteriorly outside GA.
Analysis
The composite pseudocolor images and en face angiograms of the choriocapillaris and outer retina were analyzed to identify CNV and normal choroidal vascular networks by two independent graders (A.A.F. and P.L.N.). We used the pseudocolored images to grade the CNV and normal choroidal vessels as either inside or outside the area of GA. We also compared the en face appearance of anteriorly displaced normal choroidal vessels in treatment-naive GA eyes to GA eyes after anti-VEGF for CNV. To do this, we analyzed the en face pseudocolored images for qualitative differences, including vessel caliber, branching patterns, tortuosity, and spacing between vessels. Cross-sectional OCT with overlaid flow was used as the final arbitrator for the presence of CNV, which we defined as flow signal located above the Bruch membrane that was not due to retinal projection artifacts.
To validate the location of normal choroidal vessels within GA and confirm the absence of image artifacts, we manually segmented a 16-mm thick en face slab on OCTA (31 mm-47 mm below RPE reference) to incorporate the anatomical choriocapillaris, as shown in Figure 2 . En face structural OCT of this slab and OCT B-scans were compared with the angiogram to assess the location of large choroidal vessels in the areas of atrophy ( Figure 2 ). We also used crosssectional OCT to compare the location of major choroidal vessels outside the areas of atrophy with respect to the RPE.
Histology and Electron Microscopy
Donor eye tissue from an 87-year-old white male with clinically diagnosed late-stage AMD with GA (without CNV) was obtained in accordance with the Declaration of Helsinki and processed for transmission electronic microscopy (Figures 3-5) with methods similar to those previously described. 26 After the tissue was fixed, ultrathin sections were cut with a microtome (Ultramicrotome UCT; Leica Microsystems, Wetzlar, Germany), stained with uranyl acetate and lead citrate, and analyzed by transmission electronic microscopy (H7600; Hitachi, Tokyo, Japan).
Results

Demographic and Clinical Data
A total of 40 eyes from 33 patients with GA were included for this analysis. Of these, eight eyes of seven 9 : treated). Differences in age and visual acuity were not significant between groups (P = 0.37 and P = 0.99, respectively) (see Table 1 , Supplemental Digital Content 1, http://links.lww.com/IAE/A719).
Optical Coherence Tomography Angiography Findings (Preprocessing)
All 40 eyes (100%) had distinct networks of largersized vessels visible on the choriocapillaris angiogram ( Figure 1 : treatment-naive and Figure 9 : treated). On cross-sectional OCT, these vessels were consistent with normal choroidal vessels that have been displaced anteriorly in the areas of GA and were closely abutting, but not infiltrating or above, the Bruch membrane (Figure 2 : treatment-naive). Using a thin slab on OC-TA and correlating with en face structural OCT and cross-sectional OCT, we found that the appearance of large choroidal vessels in the choriocapillaris slab was not due to any OCTA image artifact (Figure 2 : treatment-naive). Major choroidal vessels in the areas outside of GA were located more posteriorly and were not closely abutting the Bruch membrane ( Figure 6 : treatment-naive). In a majority of eyes (30 of 40 eyes: 75.0%), normal choroidal vascular networks in the areas of GA were visualized in the outer retinal OCTA slab because of failure of the segmentation algorithm. This occurred in 5 of the 8 treatment-naive eyes with GA (62.5%) (Figure 7 : treatment-naive). We found no apparent difference in the en face OCTA choroidal vascular appearance in GA when comparing anti-VEGF treated eyes to treatment-naive eyes.
Transmission Electron Microscopy of the Choroid in a Donor Eye With Treatment-Naive Geographic Atrophy
In a donor eye with treatment-naive GA, Figure 3 shows transmission electronic microscopy findings in a region where the RPE and photoreceptors are intact, outside the zone of GA. The overlying photoreceptors appear disorganized. A choriocapillaris blood vessel abuts the Bruch membrane, as evidenced by an endothelial cell lining with very thin processes, tight junctions, and numerous fenestrations, as well as an absence of pericytes. 27, 28 Figure 4 (same eye as Fig. 3 . Transmission electron microscopy of inferior choroid outside the area of GA. Treatment-naive donor eye with GA from an 87-year-old white male. In this area outside of GA, the retinal pigment epithelium and photoreceptors are present, but the photoreceptors appear disorganized. This blood vessel appears to be the choriocapillaris because it lacks pericytes and the endothelial cells have very thin processes, as well as numerous fenestrations and tight junctions. Figure 3) shows transmission electronic microscopy images within the area of GA, which illustrate anteriorly displaced intermediate choroidal blood vessels into the zone where choriocapillaris was once present. Figure 4 highlights a choroidal venule closely abutting (about 1 mm-2 mm from) the Bruch membrane in an area of GA. The blood vessel seemed to be a venule because it had pericytes enwrapping the entire blood vessel and it lacked fenestration of choriocapillaris. In addition, there was a degenerate cell process between the Bruch membrane and the vessel wall, perhaps a remnant of past choriocapillaris. Figure 5 (same eye) highlights another larger choroidal blood vessel closely abutting the Bruch membrane within the area of GA.
Optical Coherence Tomography Angiography Findings (Postprocessing)
Image postprocessing successfully highlighted the choroidal vasculature within the areas of atrophy compared with areas with intact RPE, where choroidal vasculature was less visible (Figure 1 : treatment-naive). This was useful for illustrating the extent and location of GA when interpreting en face OCTA and prompted a careful examination of the cross-sectional OCTA to further assess the exact location of the vascular networks within the area of GA in relationship to the Bruch membrane. Cross-sectional OCTA was needed to confirm the presence of CNV in all cases because the distinction between CNV and normal choroidal vessels was not possible using en face OCTA alone (Figure 2 : treatment-naive and Figure 9 : treated). In many cases, we found CNV and normal choroidal vascular networks to be similar in morphology (Figures 2, 6 , and 7: treatment-naive and Figure 9 : treated). Figure 2 shows a choroidal vascular network located below the Bruch membrane that has a similar appearance to a CNV membrane and may represent a neovascular formation that has not yet infiltrated above the Bruch membrane. 21 We also found that the loss of RPE within atrophy can lead to failure of the segmentation algorithm on OCTA, particularly of the outer retinal slab (with projection artifact removal), which is routinely used to identify the presence of CNV. In general, the OCTA segmentation boundaries of the outer retinal slab were misplaced into the choroid in the areas of atrophy, causing the normal choroidal vascular networks to be artifactually displayed in this slab. This simulated the appearance of a tangled vascular network, which could be misinterpreted as CNV on en face OCTA (Figures 6 and 7: treatment-naive). Twenty-eight of the treated eyes (87.5%) in our cohort contained some degree of fibrosis, subretinal hyperreflective material, CNV, or blood in the outer retina, which further complicated the interpretation of en face OCTA, whereas only one treatment-naïve eye (12.5%) had these findings.
Of the 32 eyes with previous anti-VEGF treatment, 23 eyes (71.9%) had residual evidence of CNV ( Figures 8 and 9 : treated), whereas 9 eyes (28.1%) did not show evidence of residual pathological blood vessels on OCTA and had a similar appearance to the angiograms of the treatment-naive group. All 23 eyes with CNV on en face OCTA were confirmed by the presence of flow signal between the Bruch membrane and the RPE or above the RPE, on cross-sectional OCTA. Of these 23 eyes, 8 eyes (34.8%) showed CNV along the borders of atrophy (Figure 8 : treated), and 15 eyes (65.2%) showed CNV primarily within the area of atrophy (Figure 9 : treated). We were not able to identify residual RPE signature on crosssectional OCT in these CNV lesions that were located within the area of atrophy (Figure 9 : treated). 
Discussion
In this study, we demonstrate a novel postprocessing approach to highlight the areas of atrophy on en face OCTA to facilitate the detection of CNV in eyes with complex AMD pathology. Our algorithm incorporates structural (OCT) and flow information (OCTA) from both the choriocapillaris and outer retina in a single image, which has not been demonstrated previously. We found that en face OCT angiograms in eyes with atrophy were difficult to interpret due to the presence of anteriorly displaced normal choroidal blood vessels that closely abut the Bruch membrane. In this series of 40 eyes with atrophy and CNV, we found that crosssectional OCTA was necessary for the accurate interpretation of en face OCTA, especially in eyes with suspicion of combined atrophy/CNV phenotype in AMD.
Geographic atrophy and CNV, the two forms of advanced AMD, have classically been considered as two distinct entities. However, many studies have Fig. 7 . Normal choroidal vessels artifactually appearing in the outer retinal slab of a treatment-naive eye with GA. A. Optical coherence tomography angiography of the choriocapillaris and cross-sectional OCT with red segmentation boundary lines. B. Optical coherence tomography angiography of the outer retina and cross-section with green and red segmentation boundary lines. Segmentation error (outer segmentation boundary displaced posteriorly in GA) and the anterior displacement of normal choroidal vessels cause vessels to appear in the outer retinal slab. C. En face structural OCT slab of the choroid used to select the area of GA and cross-sectional OCT with red segmentation boundary lines. D. Pseudocolored OCTA of the choriocapillaris and cross-sectional OCT with red flow overlay. In this figure, we added an extra postprocessing step where blood vessels appearing in the outer retinal slab are pseudocolored green and overlaid onto the choriocapillaris. Vessels with morphology suspicious for CNV are highlighted by the circle. Blue arrow on the cross-sectional OCTA confirms that these vessels are below the Bruch membrane and therefore not CNV. reported GA and CNV occurring in the same eye, simultaneously. 9-12,29-31 Sarks et al 9 were the first to describe the development of CNV on fluorescein angiography in 3.4% of patients clinically diagnosed with GA during a 6-month follow-up. Clinical and histological evidence of CNV outside the area of atrophy in patients with baseline GA suggest that new vessel growth could be dependent on the angiogenic factors secreted from viable RPE. 9, 11, 20 Indeed, loss of choriocapillaris is known to extend beyond the area of CNV into a zone with viable overlying RPE cells, which are presumed to be hypoxic. 32 It has been suggested that angiogenic factors such as VEGF, released by these hypoxic RPE cells, may stimulate the formation of new vessels, which, in turn, may provide oxygen and nutrients to the RPE. More recent reports have characterized RPE and choriocapillaris atrophy, clinically similar to de novo GA, in patients undergoing intravitreal anti-VEGF therapy for CNV. 6, 7, 33, 34 It remains to be confirmed whether RPE atrophy is the final evolution of treated neovascular AMD, regardless of the frequency or type of anti-VEGF.
Although our study design does not allow us to gain insights into the pathogenesis of AMD or the order in which concurrent GA and CNV occurs, OCTA and the proposed algorithm provide a useful tool to improve the distinction of these lesions. The interpretation of en face OCTA in the areas of RPE atrophy was complicated by the anterior displacement of residual medium-sized choroidal vessels. We confirmed this finding using a thin segmentation slab and correlating the flow signal on en face OCTA with the location of choroidal vessels on en face structural OCT and crosssectional OCT (Figure 2 ). Furthermore, we add evidence from electron microscopy of a donor eye showing anterior displacement of an intermediate-sized choroidal venule, lying 1 mm to 2 mm from the Bruch membrane, much closer than would be expected in a healthy eye (Figures 4 and 5) . We compared the region of atrophy in the donor eye (Figures 4 and 5 ) to an area with viable RPE and intact choriocapillaris (Figure 3) . McLeod et al 20 have also previously provided histopathology examples of atrophic versus nonatrophic areas. Histopathologic studies have shown a wider zone of loss of choriocapillaries around CNV underneath viable RPE, whereas disruption of the choriocapillaris is constrained within the borders of RPE loss in GA. In general, these studies and other similar ones focused on the choriocapillaris have not characterized the remodeling of the remaining choroid in these eyes. 20 In this study, we extend these findings to show that choroidal remodeling occurs in these areas of choriocapillaris atrophy, with larger choroidal vessels moving anteriorly into the space originally occupied by the choriocapillaris. Using structural OCT, we previously suggested this finding of anterior displacement of larger choroidal vessels to replace the atrophic choriocapillaris in eyes with AMD and reticular pseudodrusen. 35 The complexity of interpreting OCTA in eyes with atrophy and anterior displacement of choroidal vessels was further exacerbated by software artifacts leading to the displacement of the segmentation lines deeper into the choroid because of thinning of the RPE-Bruch membrane boundary. It seems that when the RPE is Fig. 9 . Choroidal neovascularization within the area of GA. A. Optical coherence tomography angiography of the choriocapillaris and cross-sectional OCT with red segmentation boundary lines. The diffuse network of choroidal vessels visible throughout the scan could either be normal choroidal vessels or CNV. B. En face OCTA of the outer retina reveals flow signal suspicious for CNV. Cross-sectional OCT with green and red segmentation boundary lines shows subretinal hyperreflective material above the RPE also suggestive of CNV (red arrow). C. En face structural OCT slab of the choroid used to select the area of RPE atrophy and cross-sectional OCT with red segmentation boundary lines. D. Pseudocolored OCTA of choriocapillaris and cross-sectional OCT with red flow overlay. Vessels in the area of GA (entire scan) are pseudocolored on a spectrum from blue to yellow. Vessels appearing in the outer retina are pseudocolored green. This image illustrates that the CNV is entangled within the normal choroid. Crosssectional OCTA reveals a subtle CNV lesion with red flow signal within the subretinal hyperreflective material lesion (red arrow). absent or disrupted, the algorithm artifactually uses the Bruch membrane as a surrogate for the RPE reference line. This is especially pertinent to eyes with pure GA without evidence of CNV, where this artifact caused normal choroidal vessels to be artifactually detected in the outer retinal slab on OCTA, masquerading as CNV (Figure 7) . Even as segmentation and projection removal algorithms improve, the anterior displacement of choroidal vessels in the areas of atrophy will likely still present a challenge for interpreting OCTA in eyes with CNV and atrophy. For example, using manual segmentation of the choriocapillaris slab just below the RPE, large choroidal vessels can still be visualized in the areas of atrophy (Figure 2) . Furthermore, we found that the segmentation algorithm and the process of projection artifact removal can fail in eyes with significant structural changes from pathology, such as subretinal hyperreflective material, pigment epithelial detachments, subretinal fibrosis, or subretinal fluid ( Figure 9 ). In our cohort, most treated eyes contained some degree of fibrosis, subretinal hyperreflective material, CNV, or blood in the outer retina, whereas only one treatment-naive patient had such findings. These software failures can be most disruptive in eyes with GA and suspected CNV, where we believe clinicians should use caution when interpreting en face OCTA. The presence of cross-sectional OCTA flow signal above the Bruch membrane should be used in these eyes as the sine qua non for the presence of CNV.
Determining the anatomical location of flow signal becomes even more critical with the possibility of neovascular buds or formations in the choriocapillaris, which may be precursors of CNV, yet lie below the Bruch membrane. In a recent histopathological study, Seddon et al found that neovascular formations (below the Bruch membrane) were present in 40% of eyes with intermediate AMD. These neovascular formations were not yet visible clinically, leading the authors to speculate that they may be the choroidal precursors to clinically discerned CNV. 21 Because of the distinct CNV morphology, we believe that we could visualize such choroidal neovascular precursors in our OCTA study. Figure 2 (circle) represents one of these potential CNV precursors, which could be discerned below the Bruch membrane.
In this study, we found eight CNV lesions located outside of or closely abutting the borders of GA, consistent with histological studies. 20, 32 By contrast, we also found 15 CNV lesions (undergoing anti-VEGF therapy) that were primarily located within the zone of atrophy. This finding is consistent with the findings in the Comparison of Age-Related Macular Degeneration Treatments Trials study participants, where most of the incident atrophy developed within or near the original CNV lesions. 6 In these eyes, we could not identify the signature of RPE overlying the CNV lesions on OCT. This does not necessarily preclude the possibility that isolated microscopic islands of RPE cells, beyond the resolution of OCT, were still present. Future studies using polarizationsensitive OCT could be helpful to further examine RPE alteration overlying these CNV lesions. 36 Using histological methods, McLeod et al 20 have shown that viable RPE cells overlie CNV lesions in combined GA/CNV phenotypes, but these studies predated anti-VEGF therapy. To the best of our knowledge, there have not been histological studies in eyes that developed atrophy in the setting of anti-VEGF therapy for CNV.
Limitations to this study include the cross-sectional nature making it impossible to determine which phenotype (atrophy or CNV) occurred first in eyes demonstrating the combined phenotype. We were also limited by a small number of eyes in this study, which may reflect the small percentage of eyes in our practice that develop the combined atrophy/CNV phenotype. Similarly, the number of treated and treatment-naive eyes was not balanced and the two groups were not sex matched. Furthermore, SD-OCTA has limited depth penetration in the choroid because of inherent signal attenuation, precluding high-resolution visualization of the choriocapillaris underneath healthy RPE. Future studies using swept-source OCTA may be useful in this regard. It is important to note that failures of the segmentation algorithm described in this study may not extend to other commercial OCTA devices because each uses its own specific parameters for segmentation. Finally, because of anatomical variance between individuals, additional donor eyes are needed to confirm our findings.
In conclusion, using an OCTA postprocessing approach, we have successfully highlighted atrophy and improved the interpretation of the OCT angiograms in complex AMD cases where CNV and atrophy coexist. We found the algorithm particularly useful when normal choroidal blood vessels are displaced anteriorly in the areas of pure atrophy, simulating CNV, which would complicate the interpretation of OCTA in these eyes. We also found that cross-sectional OCTA used in conjunction with en face OCTA was necessary for confirming the presence of CNV, especially given the potential for segmentation artifacts in these cases. Future longitudinal studies using our hybrid algorithm may allow clinicians to document the development of new CNV or GA in eyes with baseline pure phenotype and will be critical in elucidating the pathogenesis and course of the combined atrophy and CNV phenotype in AMD.
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